XML 24 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Class A & B common stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Jan. 31, 2020   149,095,583      
Beginning balance at Jan. 31, 2020 $ 1,665,594 $ 1 $ 745,475 $ 919,658 $ 460
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   1,839,723      
Issuance of common stock upon    exercise of stock options 34,816 $ 1 34,815    
Issuance of common stock upon vesting of restricted stock units (in shares)   1,121,502      
Stock-based compensation expense 185,380   185,380    
Other comprehensive income (loss) 532       532
Net income 379,998     379,998  
Ending balance (in shares) at Jan. 31, 2021   152,056,808      
Ending balance at Jan. 31, 2021 2,266,320 $ 2 965,670 1,299,656 992
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   1,476,898      
Issuance of common stock upon    exercise of stock options 51,538   51,538    
Issuance of common stock upon vesting of restricted stock units (in shares)   854,536      
Shares withheld related to net share settlement (in shares)   (191,645)      
Shares withheld related to net share settlement (56,398)   (56,398)    
Stock-based compensation expense 235,737   235,737    
Other comprehensive income (loss) (12,950)       (12,950)
Net income 427,390     427,390  
Ending balance (in shares) at Jan. 31, 2022   154,196,597      
Ending balance at Jan. 31, 2022 $ 2,911,637 $ 2 1,196,547 1,727,046 (11,958)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 3,421,303 3,421,303      
Issuance of common stock upon    exercise of stock options $ 43,654   43,654    
Issuance of common stock upon vesting of restricted stock units (in shares)   968,004      
Shares withheld related to net share settlement (in shares)   (341,297)      
Shares withheld related to net share settlement (63,654)   (63,654)    
Stock-based compensation expense 356,080   356,080    
Other comprehensive income (loss) (19,171)       (19,171)
Net income 487,706     487,706  
Ending balance (in shares) at Jan. 31, 2023   158,244,607      
Ending balance at Jan. 31, 2023 $ 3,716,252 $ 2 $ 1,532,627 $ 2,214,752 $ (31,129)